Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Mansouri

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Epigenetics|April 30, 2016
Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2Sujata Bhoi, Viktor Ljungström, Panagiotis Baliakas, et al.
Haematologica|November 22, 2015
UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?Sujata Bhoi, Panagiotis Baliakas, Diego Cortese, et al.
Epigenetics|June 21, 2019
EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemiaSubazini Thankaswamy Kosalai, Mohammad Hamdy Abdelrazak Morsy, Nikos Papakonstantinou, et al.
American Journal of Hematology|June 8, 2012
Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemiaLarry Mansouri, Rebeqa Gunnarsson, Lesley-Ann Sutton, et al.
Epigenetics|April 2, 2014
microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemiaStefan Deneberg, Meena Kanduri, Dina Ali, et al.
American Journal of Hematology|April 27, 2013
Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patientsLarry Mansouri, Pawel Grabowski, Sofie Degerman, et al.
British Journal of Haematology|August 12, 2020
Risk-adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real-world report on 141 consecutive Swedish patientsAgnes Mattsson, Sandra E Sylvan, Anna Asklid, et al.
Acta Oncologica (Stockholm, Sweden)|February 13, 2021
PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNSMaysaa Abdulla, Andrei Alexsson, Christer Sundström, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 3, 2012
IGHV3-21 gene frequency in a Swedish cohort of patients with newly diagnosed chronic lymphocytic leukemiaNicola Cahill, Lesley-Ann Sutton, Mattias Jansson, et al.
Genes, Chromosomes & Cancer|October 14, 2021
Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technologyAron Skaftason, Ying Qu, Maysaa Abdulla, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Epigenetics|April 30, 2016
Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2Sujata Bhoi, Viktor Ljungström, Panagiotis Baliakas, et al.
Haematologica|November 22, 2015
UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?Sujata Bhoi, Panagiotis Baliakas, Diego Cortese, et al.
Epigenetics|June 21, 2019
EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemiaSubazini Thankaswamy Kosalai, Mohammad Hamdy Abdelrazak Morsy, Nikos Papakonstantinou, et al.
American Journal of Hematology|June 8, 2012
Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemiaLarry Mansouri, Rebeqa Gunnarsson, Lesley-Ann Sutton, et al.
Epigenetics|April 2, 2014
microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemiaStefan Deneberg, Meena Kanduri, Dina Ali, et al.
American Journal of Hematology|April 27, 2013
Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patientsLarry Mansouri, Pawel Grabowski, Sofie Degerman, et al.
British Journal of Haematology|August 12, 2020
Risk-adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real-world report on 141 consecutive Swedish patientsAgnes Mattsson, Sandra E Sylvan, Anna Asklid, et al.
Acta Oncologica (Stockholm, Sweden)|February 13, 2021
PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNSMaysaa Abdulla, Andrei Alexsson, Christer Sundström, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 3, 2012
IGHV3-21 gene frequency in a Swedish cohort of patients with newly diagnosed chronic lymphocytic leukemiaNicola Cahill, Lesley-Ann Sutton, Mattias Jansson, et al.
Genes, Chromosomes & Cancer|October 14, 2021
Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technologyAron Skaftason, Ying Qu, Maysaa Abdulla, et al.
Pageof 7